
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [VRTX] Vertex Pharmaceuticals Inc.
Data updated 2025-Apr-29 (Tuesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-Apr-29 Tuesday
Open | $494.26 | High | $506.96 +2.57% |
---|---|---|---|
Close | $503.50 | Low | $490.85 -0.69% |
Volume | 1.15 Million 1.07x | Volatility | 3.28% |
Change |
+$7.01
+1.41%
|
Streak | ↑ 6 days +5.44% |
20d SMA | $486.69 +3.5% | 50d SMA | $490.15 +2.7% | 100d SMA | $464.90 +8.3% | 200d SMA | $471.31 +6.8% |
RSI | 59 | MACD | 1.57 | ADX | 23.7 | Stochastic Oscillator | 88.9 85.6 |
CCI | 136.7 | ATR | 14.51 | OBV | 218 Million | Chaikin A/D | 474 Million |
Market Cap | 106 B | PEG Ratio | 0.55 | Trailing P/E | 29.5 | Forward P/E | 25.1 |
Price/Sales (ttm) | 10.8 | Price/Book (mrq) | 6.02 | EV/Revenue (ttm) | 9.65 | EV/EBITDA (ttm) | 20.7 |
% Held by Insiders | 0.11% | % Held by Institutions | 95.84% | Shares Short | 4.13 M | Shares Short (prior month) | 4.13 M |
Short Ratio | 3.77 | Short % of Outstanding | 1.60% | Short % of Float | 1.60% | Shares Short Change (mom) | 0.0% |
Revenue/Share (ttm) | $38.30 | Profit Margin (ttm) | 36.68% | Operating Margin (ttm) | 37.97% | EBITDA (ttm) | 4.48 B |
Diluted EPS (ttm) | $13.86 | Current Ratio (mrq) | 3.99 | Return on Assets (ttm) | 13.17% | Return on Equity (ttm) | 22.99% |
Qtr Earnings Growth (yoy) | 18.30% | Qtr Revenue Growth (yoy) | 9.30% | Operating Cash Flow (ttm) | 3.54 B | Free Cash Flow (ttm) | 3.51 B |
Choose view type
Daily Performance for Vertex Pharmaceuticals Inc.. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Vertex Pharmaceuticals Inc. up to close of 2025-Apr-29 at $503.50
2-month Performance Benchmarks for Vertex Pharmaceuticals Inc.:
Related to Vertex Pharmaceuticals Inc.
Information for Vertex Pharmaceuticals Inc.
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-29 on Google
SEC Reports : Quarterly reports around 2025-Apr-29 on SEC Edgar
Compare Vertex Pharmaceuticals Inc. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Vertex Pharmaceuticals Inc.
Industry : Biotechnology industry performance which includes Vertex Pharmaceuticals Inc.